Conflict of interest statement: Yoon-Koo KangConsulting or Advisory Role: DAEHWA 
Pharmaceutical, Bristol Myers Squibb, Zymeworks, ALX Oncology, Amgen, Novartis, 
Macrogenics, Surface Oncology, Blueprint Medicines Suzanne GeorgeStock and Other 
Ownership Interests: Abbott LaboratoriesConsulting or Advisory Role: Blueprint 
Medicines, Deciphera, Bayer, Lilly, UpToDate, Research to Practice, MORE Health, 
Daiichi, KayotheraResearch Funding: Blueprint Medicines, Deciphera, Daiichi 
Sankyo RD Novare, Merck, Eisai, SpringWorks TherapeuticsPatents, Royalties, 
Other Intellectual Property: UptoDateExpert Testimony: BayerOther Relationship: 
Research to Practice, WCG Robin L. JonesConsulting or Advisory Role: Lilly, 
Immune Design, Merck Serono, Adaptimmune, Daiichi Sankyo, Eisai, Morphotek, 
TRACON Pharma, Immodulon Therapeutics, Deciphera, PharmaMar, Blueprint 
Medicines, Clinigen Group, Epizyme, Boehringer Ingelheim, Bayer, Karma Oncology, 
UpToDateResearch Funding: GlaxoSmithKlineTravel, Accommodations, Expenses: 
PharmaMar Piotr RutkowskiHonoraria: Bristol Myers Squibb, MSD, Novartis, Roche, 
Lilly, Pfizer, Pierre Fabre, Sanofi, MerckConsulting or Advisory Role: Novartis, 
Blueprint Medicines, Bristol Myers Squibb, Pierre Fabre, MSD, AmgenSpeakers' 
Bureau: Pfizer, Novartis, LillyResearch Funding: Novartis, Roche, Bristol Myers 
SquibbTravel, Accommodations, Expenses: Orphan Europe, Pierre Fabre Olivier 
MirStock and Other Ownership Interests: Transgene, Amplitude Surgical, 
IpsenHonoraria: RocheConsulting or Advisory Role: Lilly, Pfizer, Roche, 
Lundbeck, JanssenSpeakers' Bureau: Lilly, Roche, PfizerResearch Funding: Ipsen, 
AstraZeneca, Blueprint MedicinesTravel, Accommodations, Expenses: Roche, Pfizer 
Shreyaskumar PatelConsulting or Advisory Role: Novartis, Immune Design, MaxiVax, 
Epizyme, Janssen, Lilly, Daiichi Sankyo, Bayer, Dova Pharmaceuticals, 
DecipheraResearch Funding: Blueprint Medicines, Hutchinson Med Pharma Margaret 
von MehrenConsulting or Advisory Role: Deciphera, ExelixisResearch Funding: 
ArQule, Novartis, Blueprint Medicines, Deciphera, Gradalis, Springworks 
Therapeutics, Lilly, Arog, Genmab, ASCOTravel, Accommodations, Expenses: 
Deciphera Pharmaceuticals, NCCNOther Relationship: NCCN Peter 
HohenbergerHonoraria: Roche, AstraZeneca, GlaxoSmithKline, BLUMedicine, 
NovartisConsulting or Advisory Role: Nanobiotix, PfizerResearch Funding: 
Novartis, Siemens Healthcare DiagnosticsTravel, Accommodations, Expenses: 
PharmaMar Victor VillalobosEmployment: Janssen OncologyConsulting or Advisory 
Role: Janssen, Lilly, Novartis, AbbVie, Ignyta, Agios, Epizyme, Blueprint 
Medicines, Springworks Therapeutics, NanoCarrier, Daiichi SankyoTravel, 
Accommodations, Expenses: Lilly, Janssen, Xencor, GenMab, Epizyme Mehdi 
BrahmiExpert Testimony: BayerTravel, Accommodations, Expenses: PharmaMar, 
Mundipharma William D. TapLeadership: Certis Oncology Solutions, Atropos, Innova 
TherapeuticsStock and Other Ownership Interests: Certis Oncology Solutions, 
AtroposConsulting or Advisory Role: EMD Serono, Lilly, Daiichi Sankyo, Blueprint 
Medicines, Agios, NanoCarrier, Deciphera, C4 Therapeutics, Mundipharma, Adcendo, 
Ayala Pharmaceuticals, Kowa Pharmaceutical, Servier, AbMaxBioResearch Funding: 
Novartis, Lilly, Plexxikon, Daiichi Sankyo, TRACON Pharma, Blueprint Medicines, 
Immune Design, BioAtla, DecipheraPatents, Royalties, Other Intellectual 
Property: Companion Diagnostic for CDK4 inhibitors—14/854,329, Enigma and CDH18 
as companion Diagnostics for CDK4 inhibition—SKI2016-021-03 Jonathan 
TrentConsulting or Advisory Role: Novartis, Lilly, Janssen, Blueprint Medicines, 
Deciphera, Daiichi Sankyo, Epizyme, Agios, C4 Therapeutics, Bayer Patrick 
SchöffskiHonoraria: Deciphera, Blueprint Medicines, Boehringer 
IngelheimConsulting or Advisory Role: Blueprint Medicines, Ellipses Pharma, 
Adaptimmune, Intellisphere, Transgene, Deciphera, Exelixis, Boehringer 
Ingelheim, Medscape, Guided Clarity, Ysios Capital, Studiecentrum voor 
KernenergieResearch Funding: CoBioRes NV, Eisai, G1 Therapeutics, Novartis, 
PharmaMarTravel, Accommodations, Expenses: MSD, Ipsen, Boehringer Ingelheim 
Kevin HeEmployment: Blueprint Medicines, AgiosStock and Other Ownership 
Interests: Blueprint Medicines, Agios, Incyte Paggy HewEmployment: Blueprint 
MedicinesStock and Other Ownership Interests: Blueprint MedicinesTravel, 
Accommodations, Expenses: Blueprint Medicines Kate NewberryEmployment: Blueprint 
MedicinesStock and Other Ownership Interests: Blueprint Medicines Maria 
RocheEmployment: Blueprint Medicines, EpizymeStock and Other Ownership 
Interests: Blueprint Medicines, Epizyme Michael C. HeinrichStock and Other 
Ownership Interests: MolecularMDHonoraria: NovartisConsulting or Advisory Role: 
MolecularMD, Novartis, Blueprint Medicines, Deciphera, Theseus 
PharmaceuticalsPatents, Royalties, Other Intellectual Property: Patent on 
treatment of GIST-licensed to NovartisExpert Testimony: Novartis Sebastian 
BauerHonoraria: Novartis, Pfizer, Bayer, Pharmamar, GlaxoSmithKlineConsulting or 
Advisory Role: Blueprint Medicines, Bayer, Lilly, Deciphera, Nanobiotix, Daiichi 
Sankyo, Exelixis, Janssen-Cilag, ADC Therapeutics, Mundipharma, 
GlaxoSmithKlineResearch Funding: Blueprint Medicines, Novartis, IncyteTravel, 
Accommodations, Expenses: PharmamarNo other potential conflicts of interest were 
reported.